{"ticker": {"uuid": "3a5d33fd-be4c-422b-935c-a03cd6ca6008", "symbol": "GILD", "name": "Gilead Sciences, Inc.", "exchange": "BUE", "country": "AR", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNeXdaLWxrMGF4NG5FWTk5YVB0UDVLb1lJWXlFQWxZcHQzcG4xRkxpRFdZa2ZQM2YyUHNGUDQyZmtDQzM0TjRBZDFHMW81d1hfR1ZQMHE1ZzJJRjdEY0NpeTJWNk1lcDYySlE1RG0zelZ3TkNZa0F3NnFPTHg3Sjc1aENJV1prUlYtNFROVDgxMVZJd2FYUlg2bVc1cw?oc=5", "source_name": "Market source", "published_at": "2026-07-17T22:00:04+00:00", "published_display": "17 Jul 2026 22:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Inc (GILD) Stock Up 3.5% but GF Value Says Overv", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxOc2ItdkhkVzNwMGdOYjZWX1Q2dFFXNzRBT1h5SzJmWGl3QVFfNkhTR2FuU1B5RVUwQk9obVpqT0pPdzNzeWRfTDJxbzZQVjhBMkpCVTVpUi1aelZET2ZiOGhFalNrRjVJVGhZc1c5NG9mamcySXNmaE5nRm1oZnNfMlUwT0dQZE51SHcyOUR3SG15WFhrOElXeVFlbGw5VmJfbkhEYzhPVWl2ajUzZ05RV180eTJ0eDVmMnlPeU1EQkx4MEdDcy0yQzBHYw?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-16T21:35:27+00:00", "published_display": "16 Jul 2026 21:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences (NASDAQ: GILD) exec trades 3,000 shares under 10b5-1 plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOZFYxNFltWHNNWXR0X0djdnRuVmRIV1IxLVdpRUpBOUZkZUZkNkkzQUJpZVAyVXFmNy1sRVVBdnpQWDlrTlNyZXZiaElvOHZuYjFuNHZnM1V0SUFqal9VNTNUX0kwZWx3b0JiOF9HVUpSS2J4WXZES3RWd0dOVHlhT3l4U3AxbVZIWWppeXVCUlhhYTZLUkpLV3V5SkY5UERINnFNcXBlSzFvelZZZktUaUo0RQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-16T20:55:08+00:00", "published_display": "16 Jul 2026 20:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Planned 3,000-share sale by Gilead (NASDAQ: GILD) shareholder Johanna Mercier", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNazZnaTl3TmFwNDR3MVdGc3h5eVNtbG82SFFaR2FvWU9iY3VCWlk0d0lVc2Rsb3kzamM0ck52aFhUVVRjc0RvUXlxVnBHd0tRUnlMaGFLbUtyV2c5VG0wV09HaVBQRHJYdE4yZy1ndk9uMFBJRHVwekQzb25DVjNoVGRiQkZDZ2FwTnRENXRSc2pTNERxOUxUMWp3OG0?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-15T20:13:43+00:00", "published_display": "15 Jul 2026 20:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences, Inc. (GILD) Stock Analysis: Promising 21.93% Upside Amid Strong Buy Ratings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxPLUE4TjFuWVFnYXp6R2NkZlhUblVRRkw5NTRpTGt0ZGhzZnBXQ09ZREFvTndDYTBEeDJveC1zMGk0R09Zb3EyNllpVm9vRmdtM2k2T3ByMy1uNFpTWENNT0p2TmxRcnlmd0E3bEFPbTM1eGN2Z1czNnY3UG0tdTF0ZUdhNXYxMnFkc0NwRVNyMlZENkNac0lvMHgtaGx1YkRjc2dEbmcxN21KNFZ3cHpHTGViOGVjMDIya1lmWkdPa29HaFI5VE5JazVQUi1GUTdESmJF?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:12:07+00:00", "published_display": "13 Jul 2026 09:12", "sentiment": "positive", "sentiment_pct": 95, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQclR2UzJHMm1iZG44T2dzUFpGQmh5aDVsYmI2ejZkVFk1amV2Y29QbmFCTEdzQXJvMzYwYzJoY2dvRV96RTJxQkt2dUJCV2pobDN0YnpHTmx5TlA3TnA2ZHdRM29KRkZJRjFxNEk3X3piWGFzU0FhV1ZabkFYcXZPcVNpMlpNYTFaelY5a3BnTkFfM0tBTDBsTmNPdlM?oc=5", "source_name": "Market source", "published_at": "2026-07-10T22:00:03+00:00", "published_display": "10 Jul 2026 22:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead (GILD) Stock Looks Below Fair Value But Earnings Already Look Priced In", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-09T07:00:00+00:00", "published_display": "09 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will Trodelvy\u2019s First-Line TNBC Approval Redefine Gilead Sciences\u2019 (GILD) Oncology-Led Investment Narrative?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQb1Y3U09pU3plcjhBLVR4YnlEWmpXY3dFRHI4NXlnck5mMjN2WTQ3X2IxYVlULUVSVGM2T1lFY2xIb0VqaE9rZ1NkWTBKS3FMTFpReDM5MlBZcEZfQ3lrNUxGNl9nRnBDV2cybE5LTUFJNUdIdklTRVRvbWNobkpkbU1ibDFXVkhGdjEtU2ZhdGJoUFBibldISDBB?oc=5", "source_name": "Market source", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Could This FDA Milestone Unlock Gilead\u2019s (GILD) Next Big Growth Driver?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQT29NS01sMmtTVjF4MDhFYXpGUU9yMTFVSjFIMXRkRGYxMEZXR294X2ZfU2lNbEhPQ1Qyd1hxM0JjUm00UDFfOVJEQk8xVWp3QldqRXVLb0RIZVFPdjNFUnhwS2hwbGhfVGliS0JoQzM0b3c5ZjFwQXRXNkcyS1VxRVpYMktLX2plTGdzbWtkVTUxemtfZHlCcTRn?oc=5", "source_name": "Market source", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Stock (GILD) Opinions on Recent Congressional Insider Activity", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPQk1DTTdDeWFIb0JSZWdIamtYVzlxcnJ5THpBM2lfR0VLQ1lqamRMVS16eThoOUcyZjA3UmpNTkVlVzdsYVJtV04tUy05S1NVQkZ5Q2hMa1NzUDQxUThNcU5Qc1hGSTV3NUs4eEg5azhEX0xyaWJGQm93UmFnejg2bk5UdUM3bGs2bWV6YTZ4WkJRX1RlTFR5QUI1TWNBZFpUZlMxekZYMHY4UmV2YlNHSHM1aTBpdw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences (GILD) Stock Falls Amid Market Uptick: What Investors Need to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQZ3RhTlFnWC1qTkw3YXFtQ0pBSmEtYW8zRGdPUzhJNVhQQjhBUmtlRkszQzJNaGM3MXlYb0tmV0tWWHNscG8yV1pIaXV0NnJLRVhpaF9Ub3NWYWxLOUdhQ2JrSnlkSnBHenloWGsxRUtDaHhReHNkZWVEVTA5di01ZmI3QVRVX09SREwzQkJfSUJVNGNEM1lrUVRsR3hrdw?oc=5", "source_name": "Market source", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNMHJnTEdKUFVna2R5Y2N3TlpBRVZmUkZEc01TbEt0UTMxckFidDNxTUJIZ2p2Q3ZaZ2tVS2NLNVE5bk83TU8xVURpY2lCWmFTbDBLeElnQnJoS1JONVN3azRYZV9kMHRlT3lVbU1aVzNad2QwaWpoZmJPZUp1YmRGRl8zSHlOX2k4Z1dhUm1kelJoakNxdGkwdUhfQ1NSeUZYQzhEMFFWUGg?oc=5", "source_name": "Market source", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reassess Gilead Sciences (GILD) After Strong Multi Year Share Price Gains", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNeV9feXBaekdJMVZzOEdEQzByUG1UTW0wdFRNYnhvOUxyWXR3ZDNIWWZrbmlCVEJXYWtFS1hXZndLT1g1VFVJVHlyNmNBZ0VXVVhKYVMzd2t1NS05dVZBbGcwVHI1b3NaRk5ZOEhoMW1yeTdxdWNhR0FrWFpmUUlOcHg3UkJmMUJDSHl1bW0yWWk1cm9tZmNCb21KUGo3NENP?oc=5", "source_name": "Market source", "published_at": "2026-05-23T07:00:00+00:00", "published_display": "23 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences (GILD) Stock: Surges as FDA Approves First U.S. Treatment for Hepatitis Delta", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPMkV4TWdZeG0yaEJtVVVRaVNzWURZWDYzVUhjdEJ2WDZ3QjEzaEJiVHM3SC1NU0o5bnlnaDhDSjRKT2M1RkNsVVZvUTJxTVp2VnlWMDBQNGxwR0J4VlUyNnNaNzhtY1BXVXctdmYxMHhZV2tsalVzUUJ6M3hyMkpXSHB6UWNlMFFiY1E4ckplVWozUFduQ3BNSHFKQW50YnVOSVdLcWZLZkVzaFE0TFZCag?oc=5", "source_name": "parameter.io", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Just Told Investors What to Watch Before December 23. Here\u2019s What the Data Says About GILD Stock.", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQMy1FZks3blJfcHlFUXMxclRvdWtELUZ1Vk80amFiMlJKUGdIamE3UjJmX3JmOXpUN2ZTRXBEWm5JdF9KejJXMW5DZ1k5MDlydTZUdkVxUlVUQ1JIN3I0WVowTlRRS1dscGtKOC1tQjNLZjd5dGNEanZweFp3UUsxc193blRFZjR2WjFMTVBvbUc1NS1Td29wZ0U2azEwR3IwZTdlMk9IdUhVWllacHFmVl9lR2RJNThRbWhEMjZIV2x2RUpieW83VE4xTE1mb0dmb0E?oc=5", "source_name": "TIKR.com", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences (GILD) Stock Dips Despite Q1 Beat as $11.5B Acquisition Charges Slash Annual Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNcHNuQUJuc0M4UWswNnpMMjBmdUVLQnRldU1aMlVhZmd6dXo4cUExd2pkUmpCVEhpdG9EeWc4ZWt2WUxBYnVnckdTbUttT1hHNzVaNzVVSjY0eW1ISnJFNEg2OFNxS3dFbl82TGhNbjE3MC1kLXF4NkdJVHVYU2ZVVENyNjFja2tLRzh3VlBGV0xRcU5wN2VwU0M5T09HTEhiR3BqTFFJaTQtSnFUdU5vSWxCNGVXY1Q1TkFB?oc=5", "source_name": "parameter.io", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Inc. (GILD): Growing Popularity as Defensive Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOMS1kN2xmaTh4MTlPODdvOE12di05bS1RbFhpNHg2dDJGSXlZYXV1T2MzNEYzZUMwQnB2YWZVNnZEdE51SjdFdE1nSDRRajh3Xzd4V2x1Smc1NTVFUG0xQlBjRU1ZbWUtUWE2VG03VUx2dXE0Unk1R2Nfc0VVRkFpZkh2LVZZQmlTM1lBem5xYWxVeFNUYnlCbkNIdEdEQQ?oc=5", "source_name": "Market source", "published_at": "2026-04-26T07:00:00+00:00", "published_display": "26 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Deploys $16 Billion in 60 Days: Is GILD Stock Undervalued for 2026?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQSVFlVWF4b3BsZlAtbGZmaWFxVXRfQ0V4Z0F5elpteGYzWHhvWWpxV2lKejRmTkItNDF3SDlTcXdidm1qeTRNeEU1Vl9hUGdXWlp0MVpySlFoQlVXbTFQalVWdTU3Uld1SHUxZ212MGZmakVDSUZHNmREZmN0N2IyY1FLWFNzVXFQVG1JVWM2YlFQTEtpNkNYbjg5d0JiNUp2YkYyd180dktEUQ?oc=5", "source_name": "TIKR.com", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences (GILD) Stock Declines While Market Improves: Some Information for Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNOFhxZkdLVkg0QXJ5SHZhU1ByRWZMaV9lTGxhMm9jZ3YwcFVMUG4tS24ycVljaHZqZjhJdFU4RjFaRDRjU056RVFBeWstRHliUnk5Tk1tTi11OFdXdE43aDFVcHpTVE5nNTFmNWpPQW5ucE4yT1N3aFJRSS0yNm1YTDdvT2JncDJ1?oc=5", "source_name": "Market source", "published_at": "2026-01-05T08:00:00+00:00", "published_display": "05 Jan 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Hit With Downgrades on Questions of Remdesivir Profit", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPbUFqNTF4VmJWeFF3VXlUbW1MT2sybWhlWDZZOWoyd3RHUzVSdmlKYnJYWVpCT01NeDRsazdtcTFOelR0REdEY3l0NnBqVkVBN2tKcDA5TzYwMDdWTllaU0ptdWl2Z2hKQlhfeDBWbDVaN0gtTGV0Smo3SUNheGdPYTlQelVkTi1KVFhmX1BOSnVCTVdjUG9aT1I5eU9fbkNUaVlZRjRQcF9qUlE3MFZ2cGNFaEpzZw?oc=5", "source_name": "Bloomberg.com", "published_at": "2020-05-01T07:00:00+00:00", "published_display": "01 May 2020 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNeXdaLWxrMGF4NG5FWTk5YVB0UDVLb1lJWXlFQWxZcHQzcG4xRkxpRFdZa2ZQM2YyUHNGUDQyZmtDQzM0TjRBZDFHMW81d1hfR1ZQMHE1ZzJJRjdEY0NpeTJWNk1lcDYySlE1RG0zelZ3TkNZa0F3NnFPTHg3Sjc1aENJV1prUlYtNFROVDgxMVZJd2FYUlg2bVc1cw?oc=5", "source_name": "Market source", "published_at": "2026-07-17T22:00:04+00:00", "published_display": "17 Jul 2026 22:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Inc (GILD) Stock Up 3.5% but GF Value Says Overv", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxOc2ItdkhkVzNwMGdOYjZWX1Q2dFFXNzRBT1h5SzJmWGl3QVFfNkhTR2FuU1B5RVUwQk9obVpqT0pPdzNzeWRfTDJxbzZQVjhBMkpCVTVpUi1aelZET2ZiOGhFalNrRjVJVGhZc1c5NG9mamcySXNmaE5nRm1oZnNfMlUwT0dQZE51SHcyOUR3SG15WFhrOElXeVFlbGw5VmJfbkhEYzhPVWl2ajUzZ05RV180eTJ0eDVmMnlPeU1EQkx4MEdDcy0yQzBHYw?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-16T21:35:27+00:00", "published_display": "16 Jul 2026 21:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences (NASDAQ: GILD) exec trades 3,000 shares under 10b5-1 plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOZFYxNFltWHNNWXR0X0djdnRuVmRIV1IxLVdpRUpBOUZkZUZkNkkzQUJpZVAyVXFmNy1sRVVBdnpQWDlrTlNyZXZiaElvOHZuYjFuNHZnM1V0SUFqal9VNTNUX0kwZWx3b0JiOF9HVUpSS2J4WXZES3RWd0dOVHlhT3l4U3AxbVZIWWppeXVCUlhhYTZLUkpLV3V5SkY5UERINnFNcXBlSzFvelZZZktUaUo0RQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-16T20:55:08+00:00", "published_display": "16 Jul 2026 20:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Planned 3,000-share sale by Gilead (NASDAQ: GILD) shareholder Johanna Mercier", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNazZnaTl3TmFwNDR3MVdGc3h5eVNtbG82SFFaR2FvWU9iY3VCWlk0d0lVc2Rsb3kzamM0ck52aFhUVVRjc0RvUXlxVnBHd0tRUnlMaGFLbUtyV2c5VG0wV09HaVBQRHJYdE4yZy1ndk9uMFBJRHVwekQzb25DVjNoVGRiQkZDZ2FwTnRENXRSc2pTNERxOUxUMWp3OG0?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-15T20:13:43+00:00", "published_display": "15 Jul 2026 20:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences, Inc. (GILD) Stock Analysis: Promising 21.93% Upside Amid Strong Buy Ratings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxPLUE4TjFuWVFnYXp6R2NkZlhUblVRRkw5NTRpTGt0ZGhzZnBXQ09ZREFvTndDYTBEeDJveC1zMGk0R09Zb3EyNllpVm9vRmdtM2k2T3ByMy1uNFpTWENNT0p2TmxRcnlmd0E3bEFPbTM1eGN2Z1czNnY3UG0tdTF0ZUdhNXYxMnFkc0NwRVNyMlZENkNac0lvMHgtaGx1YkRjc2dEbmcxN21KNFZ3cHpHTGViOGVjMDIya1lmWkdPa29HaFI5VE5JazVQUi1GUTdESmJF?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:12:07+00:00", "published_display": "13 Jul 2026 09:12", "sentiment": "positive", "sentiment_pct": 95, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQclR2UzJHMm1iZG44T2dzUFpGQmh5aDVsYmI2ejZkVFk1amV2Y29QbmFCTEdzQXJvMzYwYzJoY2dvRV96RTJxQkt2dUJCV2pobDN0YnpHTmx5TlA3TnA2ZHdRM29KRkZJRjFxNEk3X3piWGFzU0FhV1ZabkFYcXZPcVNpMlpNYTFaelY5a3BnTkFfM0tBTDBsTmNPdlM?oc=5", "source_name": "Market source", "published_at": "2026-07-10T22:00:03+00:00", "published_display": "10 Jul 2026 22:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead (GILD) Stock Looks Below Fair Value But Earnings Already Look Priced In", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-09T07:00:00+00:00", "published_display": "09 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will Trodelvy\u2019s First-Line TNBC Approval Redefine Gilead Sciences\u2019 (GILD) Oncology-Led Investment Narrative?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQb1Y3U09pU3plcjhBLVR4YnlEWmpXY3dFRHI4NXlnck5mMjN2WTQ3X2IxYVlULUVSVGM2T1lFY2xIb0VqaE9rZ1NkWTBKS3FMTFpReDM5MlBZcEZfQ3lrNUxGNl9nRnBDV2cybE5LTUFJNUdIdklTRVRvbWNobkpkbU1ibDFXVkhGdjEtU2ZhdGJoUFBibldISDBB?oc=5", "source_name": "Market source", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Could This FDA Milestone Unlock Gilead\u2019s (GILD) Next Big Growth Driver?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQT29NS01sMmtTVjF4MDhFYXpGUU9yMTFVSjFIMXRkRGYxMEZXR294X2ZfU2lNbEhPQ1Qyd1hxM0JjUm00UDFfOVJEQk8xVWp3QldqRXVLb0RIZVFPdjNFUnhwS2hwbGhfVGliS0JoQzM0b3c5ZjFwQXRXNkcyS1VxRVpYMktLX2plTGdzbWtkVTUxemtfZHlCcTRn?oc=5", "source_name": "Market source", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Stock (GILD) Opinions on Recent Congressional Insider Activity", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPQk1DTTdDeWFIb0JSZWdIamtYVzlxcnJ5THpBM2lfR0VLQ1lqamRMVS16eThoOUcyZjA3UmpNTkVlVzdsYVJtV04tUy05S1NVQkZ5Q2hMa1NzUDQxUThNcU5Qc1hGSTV3NUs4eEg5azhEX0xyaWJGQm93UmFnejg2bk5UdUM3bGs2bWV6YTZ4WkJRX1RlTFR5QUI1TWNBZFpUZlMxekZYMHY4UmV2YlNHSHM1aTBpdw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences (GILD) Stock Falls Amid Market Uptick: What Investors Need to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQZ3RhTlFnWC1qTkw3YXFtQ0pBSmEtYW8zRGdPUzhJNVhQQjhBUmtlRkszQzJNaGM3MXlYb0tmV0tWWHNscG8yV1pIaXV0NnJLRVhpaF9Ub3NWYWxLOUdhQ2JrSnlkSnBHenloWGsxRUtDaHhReHNkZWVEVTA5di01ZmI3QVRVX09SREwzQkJfSUJVNGNEM1lrUVRsR3hrdw?oc=5", "source_name": "Market source", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNMHJnTEdKUFVna2R5Y2N3TlpBRVZmUkZEc01TbEt0UTMxckFidDNxTUJIZ2p2Q3ZaZ2tVS2NLNVE5bk83TU8xVURpY2lCWmFTbDBLeElnQnJoS1JONVN3azRYZV9kMHRlT3lVbU1aVzNad2QwaWpoZmJPZUp1YmRGRl8zSHlOX2k4Z1dhUm1kelJoakNxdGkwdUhfQ1NSeUZYQzhEMFFWUGg?oc=5", "source_name": "Market source", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reassess Gilead Sciences (GILD) After Strong Multi Year Share Price Gains", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNeV9feXBaekdJMVZzOEdEQzByUG1UTW0wdFRNYnhvOUxyWXR3ZDNIWWZrbmlCVEJXYWtFS1hXZndLT1g1VFVJVHlyNmNBZ0VXVVhKYVMzd2t1NS05dVZBbGcwVHI1b3NaRk5ZOEhoMW1yeTdxdWNhR0FrWFpmUUlOcHg3UkJmMUJDSHl1bW0yWWk1cm9tZmNCb21KUGo3NENP?oc=5", "source_name": "Market source", "published_at": "2026-05-23T07:00:00+00:00", "published_display": "23 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences (GILD) Stock: Surges as FDA Approves First U.S. Treatment for Hepatitis Delta", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPMkV4TWdZeG0yaEJtVVVRaVNzWURZWDYzVUhjdEJ2WDZ3QjEzaEJiVHM3SC1NU0o5bnlnaDhDSjRKT2M1RkNsVVZvUTJxTVp2VnlWMDBQNGxwR0J4VlUyNnNaNzhtY1BXVXctdmYxMHhZV2tsalVzUUJ6M3hyMkpXSHB6UWNlMFFiY1E4ckplVWozUFduQ3BNSHFKQW50YnVOSVdLcWZLZkVzaFE0TFZCag?oc=5", "source_name": "parameter.io", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Just Told Investors What to Watch Before December 23. Here\u2019s What the Data Says About GILD Stock.", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQMy1FZks3blJfcHlFUXMxclRvdWtELUZ1Vk80amFiMlJKUGdIamE3UjJmX3JmOXpUN2ZTRXBEWm5JdF9KejJXMW5DZ1k5MDlydTZUdkVxUlVUQ1JIN3I0WVowTlRRS1dscGtKOC1tQjNLZjd5dGNEanZweFp3UUsxc193blRFZjR2WjFMTVBvbUc1NS1Td29wZ0U2azEwR3IwZTdlMk9IdUhVWllacHFmVl9lR2RJNThRbWhEMjZIV2x2RUpieW83VE4xTE1mb0dmb0E?oc=5", "source_name": "TIKR.com", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences (GILD) Stock Dips Despite Q1 Beat as $11.5B Acquisition Charges Slash Annual Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNcHNuQUJuc0M4UWswNnpMMjBmdUVLQnRldU1aMlVhZmd6dXo4cUExd2pkUmpCVEhpdG9EeWc4ZWt2WUxBYnVnckdTbUttT1hHNzVaNzVVSjY0eW1ISnJFNEg2OFNxS3dFbl82TGhNbjE3MC1kLXF4NkdJVHVYU2ZVVENyNjFja2tLRzh3VlBGV0xRcU5wN2VwU0M5T09HTEhiR3BqTFFJaTQtSnFUdU5vSWxCNGVXY1Q1TkFB?oc=5", "source_name": "parameter.io", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Inc. (GILD): Growing Popularity as Defensive Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOMS1kN2xmaTh4MTlPODdvOE12di05bS1RbFhpNHg2dDJGSXlZYXV1T2MzNEYzZUMwQnB2YWZVNnZEdE51SjdFdE1nSDRRajh3Xzd4V2x1Smc1NTVFUG0xQlBjRU1ZbWUtUWE2VG03VUx2dXE0Unk1R2Nfc0VVRkFpZkh2LVZZQmlTM1lBem5xYWxVeFNUYnlCbkNIdEdEQQ?oc=5", "source_name": "Market source", "published_at": "2026-04-26T07:00:00+00:00", "published_display": "26 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Deploys $16 Billion in 60 Days: Is GILD Stock Undervalued for 2026?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQSVFlVWF4b3BsZlAtbGZmaWFxVXRfQ0V4Z0F5elpteGYzWHhvWWpxV2lKejRmTkItNDF3SDlTcXdidm1qeTRNeEU1Vl9hUGdXWlp0MVpySlFoQlVXbTFQalVWdTU3Uld1SHUxZ212MGZmakVDSUZHNmREZmN0N2IyY1FLWFNzVXFQVG1JVWM2YlFQTEtpNkNYbjg5d0JiNUp2YkYyd180dktEUQ?oc=5", "source_name": "TIKR.com", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences (GILD) Stock Declines While Market Improves: Some Information for Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNOFhxZkdLVkg0QXJ5SHZhU1ByRWZMaV9lTGxhMm9jZ3YwcFVMUG4tS24ycVljaHZqZjhJdFU4RjFaRDRjU056RVFBeWstRHliUnk5Tk1tTi11OFdXdE43aDFVcHpTVE5nNTFmNWpPQW5ucE4yT1N3aFJRSS0yNm1YTDdvT2JncDJ1?oc=5", "source_name": "Market source", "published_at": "2026-01-05T08:00:00+00:00", "published_display": "05 Jan 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Hit With Downgrades on Questions of Remdesivir Profit", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPbUFqNTF4VmJWeFF3VXlUbW1MT2sybWhlWDZZOWoyd3RHUzVSdmlKYnJYWVpCT01NeDRsazdtcTFOelR0REdEY3l0NnBqVkVBN2tKcDA5TzYwMDdWTllaU0ptdWl2Z2hKQlhfeDBWbDVaN0gtTGV0Smo3SUNheGdPYTlQelVkTi1KVFhmX1BOSnVCTVdjUG9aT1I5eU9fbkNUaVlZRjRQcF9qUlE3MFZ2cGNFaEpzZw?oc=5", "source_name": "Bloomberg.com", "published_at": "2020-05-01T07:00:00+00:00", "published_display": "01 May 2020 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 80, "total_relevant": 20, "sentiment_summary": {"positive": 7, "negative": 2, "neutral": 11, "score": 56, "total": 20, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 87, "events": [{"event": "general", "label": "Market update", "weight": 8.8, "count": 16}, {"event": "earnings", "label": "Earnings", "weight": 1.45, "count": 2}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 7, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 53025.0, "latest_week": "2026-07-17", "one_week_move": 4.3, "four_week_move": 9.5, "twelve_week_move": 8.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.368059, "market_dynamics_buy_signal": false, "relative_strength": -7.561807, "fair_value_gap": 66.3, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "positive", "expectation_probability": 55.7426, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+4.3% over one week, +9.5% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 68, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 9}, {"label": "Stock Titan", "count": 2}, {"label": "parameter.io", "count": 2}, {"label": "TIKR.com", "count": 2}, {"label": "GuruFocus", "count": 1}, {"label": "DirectorsTalk Interviews", "count": 1}, {"label": "simplywall.st", "count": 1}, {"label": "Quiver Quantitative", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 20}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 16}, {"label": "Earnings", "count": 2}, {"label": "Regulatory and legal", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "56/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "87/100 classification confidence."}, {"label": "Company focus", "value": "20", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+4.3% over one week, +9.5% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know"}], "updated_at": "2026-07-18T08:47:43.011696+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}